Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts (Q44057163)

29 November 2017

Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts (English)

1 reference

29 November 2017

0 references

O Fromigué

1

1 reference

PubMed ID

12109626

29 November 2017

J J Body

series ordinal

2

1 reference

29 November 2017

1 June 2002

1 reference

Journal of Endocrinological Investigation

29 November 2017

1 reference

29 November 2017

25

1 reference

29 November 2017

6

1 reference

29 November 2017

539-546

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03345497

29 November 2017

0 references

cites work

Bisphosphonates: a review of their pharmacokinetic properties

1 reference

https://api.crossref.org/works/10.1007%2FBF03345497

Bisphosphonates act on rat bone resorption through the mediation of osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345497

Effects of two novel bisphosphonates on bone cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345497

Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345497

Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345497

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345497

Bisphosphonates induce breast cancer cell death in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345497

Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345497

The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345497

Culture and behavior of osteoblastic cells isolated from normal trabecular bone surfaces.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345497

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345497

Differential effects of transforming growth factor beta2, dexamethasone and 1,25-dihydroxyvitamin D on human bone marrow stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345497

Increase in alkaline phosphatase activity in calvaria cells cultured with diphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345497

Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345497

Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345497

Mineralisation defects with pamidronate therapy for Paget's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345497

Current and future directions in medical therapy: hypercalcemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345497

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345497

Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345497

Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345497

Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345497

A dose-finding study of zoledronate in hypercalcemic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345497

Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345497

Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345497

Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation

21 January 2018

1 reference

12 December 2020

A simplified in situ solubilization procedure for the determination of DNA and cell number in tissue cultured mammalian cells

1 reference

12 December 2020

Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis

1 reference

12 December 2020

Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption

1 reference

12 December 2020

Alendronate modulates osteogenesis of human osteoblastic cells in vitro

1 reference

12 December 2020

Cyclical intravenous clodronate in postmenopausal osteoporosis: results of a long-term clinical trial

1 reference

12 December 2020

Continuous therapy with pamidronate, a potent bisphosphonate, in postmenopausal osteoporosis

1 reference

12 December 2020

Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo

1 reference

12 December 2020

The effectiveness of cyclic and continuous oral clodronate therapy on bone density and markers in osteopenic postmenopausal women

1 reference

12 December 2020

Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts

1 reference

12 December 2020

Current use of bisphosphonates in oncology. International Bone and Cancer Study Group

1 reference

12 December 2020

Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03345497

1 reference

29 November 2017

1 reference

PubMed ID

12109626